Clinical Trial Identifier: NCT05125913


Short report 2021


  • Publications

Tanasa, A., Tapoi, L., Ureche, C., Sascau, R., Statescu, C., Covic, A. Left atrial strain: A novel “biomarker” for chronic kidney disease patients? Echocardiography 2021,1–6.

Kanbay, M., Tapoi, L., Ureche, C. et al. Effect of sodium–glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis. Int Urol Nephrol 2021.

Tanasa, A., Burlacu, A., Popa, I.V., Covic, A. Right Ventricular Functionality Following Hemodialysis Initiation in End-Stage Kidney Disease—A Single-Center, Prospective, Cohort Study. Medicina 2021, 57, 704.

Burlacu, A., Tinica, G., Brinza, C., Crisan-Dabija, R., Popa, I.V., Covic, A. Safety and Efficacy of Minimum- or Zero-Contrast IVUS–Guided Percutaneous Coronary Interventions in Chronic Kidney Disease Patients: A Systematic Review. J. Clin. Med.2021, 10, 1996.

  • Conferences

Oral presentation at Congresul Național al Societății Române de Nefrologie, 7-9 Octombrie 2021, Iași, Romania. Program here.

Oral presentation at Zilelor Cardiologice „Prof. Dr. George I. M. Georgescu”, 27-30 Octombrie 2021, Iași, Romania. Program here.